Soleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...

In the longer term, as VR and brain-computer interfaces evolve, we may reach a point where we can simulate an entire meal ...

Approval of Vykat XR marks the first treatment indicated for hyperphagia in patients with Prader-Willi syndrome.

Samsung is set to launch new XR smart glasses this year, developed under the codename Project HAEAN. These lightweight ...

Vivo has shown off its mixed reality headset The device looks just like an Apple Vision Pro It signals Vivo's big push into..

Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with ...

Since 2000, when the FDA approved recombinant human growth hormone (rhGH) for those with the rare genetic disorder ...

Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) ...

At Samsung's Galaxy Unpacked event in January, the company teased an XR headset in the vein of the Apple Vision Pro, ...

Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...

We’ve been waiting to hear about Samsung’s entrance into XR for a few years now, with the company’s still unnamed mixed ...